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adrenalectomy; calcium/calmodulin-dependent protein kinase II; calcium adenosinetriphosphatase; calcium transport A NUMBER OF STUDIES have suggested an apparent involvement of corticosteroids in the maintenance of myocardial function. Thus it is well known that adrenalectomized animals, unless supported by maintenance doses of corticosteroids, gradually develop a form of circulatory decompensation (12) . Lefer (19) observed a marked time-dependent decrease in contractile force development by papillary muscles isolated from adrenalectomized rats. Treatment of adrenalectomized rats in vivo or cardiac muscle in vitro with the synthetic glucocorticoid dexamethasone prevented the deterioration in contractile performance of cardiac muscle, and it was suggested that dexamethasone exerted a direct effect on the myocardium, possibly via effects on glycogen metabolism and on electrolyte balance (19) . It has also been reported that dexamethasone treatment significantly enhanced the development of contractile tension and increased the velocity of contraction and relaxation in cardiac muscle from dogs, cats, and rabbits (31) . While these observations suggest a likely role for glucocorticoids in the maintenance of normal contractile function of the heart, the cellular processes affected by glucocorticoids and the biochemical mechanisms underlying their action(s) have not been clarified.
By virtue of its ability to control cytosolic Ca 2ϩ concentration, the sarcoplasmic reticulum (SR) plays a central role in contractile force development and the speed of contraction and relaxation in heart muscle (3). Conceivably, the ability of glucocorticoids to augment cardiac contractile function may arise from their ability to influence the Ca 2ϩ sequestration and Ca 2ϩ release functions of the SR. Consistent with this possibility, we observed previously (23) that cardiac SR vesicles isolated from adrenalectomized rats exhibit diminished rates of ATP-energized Ca 2ϩ uptake compared with SR vesicles from control rats and that dexamethasone treatment of adrenalectomized rats results in improved Ca 2ϩ uptake activity of SR. The major Ca 2ϩ -cycling proteins in the SR include the Ca 2ϩ -sequestering ATPase (Ca 2ϩ -ATPase), the Ca 2ϩ -storage protein calsequestrin (22) , the ryanodine receptor/Ca 2ϩ -release channel (RyR-CRC) (4), and the Ca 2ϩ -ATPase-regulatory protein phospholamban (17, 34, 38) . In its unphosphorylated state, phospholamban is thought to diminish the Ca 2ϩ sensitivity of Ca 2ϩ -ATPase; phosphorylation of phospholamban by cAMPdependent protein kinase (PKA) or Ca 2ϩ /calmodulindependent protein kinase II (CaM kinase II) restores the Ca 2ϩ sensitivity (17, 34, 38) . Besides phospholamban, calmodulin and CaM kinase are tightly associated with cardiac SR and have been implicated in the mod-ulation of the Ca 2ϩ uptake and release functions of the SR through direct phosphorylation of Ca 2ϩ -ATPase (11, 26-28, 30, 40, 44-47) and RyR-CRC (10, 39, 43) . As part of an attempt to decipher the mechanisms underlying glucocorticoid modulation of cardiac contractile function, the present study investigated the effects of adrenalectomy and dexamethasone treatment on the contents of major SR Ca 2ϩ -cycling proteins, their phosphorylation by SR-associated CaM kinase II, and SR Ca 2ϩ sequestration function in the rat myocardium. Animals. Male Wistar rats weighing 250-300 g were purchased from Charles River (St. Constant, PQ, Canada). On arrival, the rats were housed individually in plastic cages in the Health Sciences Center animal care facility of this institution at 23°C on a 12:12-h light-dark cycle. The investigations were conducted under guidelines approved by the local Animal Care Committee in accordance with the standards of the Canadian Council on Animal Care. The rats were anesthetized with metofane, and bilateral adrenalectomy was performed as described previously (23) . Control animals were sham operated. The adrenalectomized animals were divided into two groups: one group received dexamethasone via a subcutaneously implanted ALZET osmotic mini pump (model 2001, flow rate 1 l/h) that delivered dexamethasone at a rate of 4 g/h for 7 days, and the second group received no dexamethasone. The adrenalectomized animals were maintained on normal saline to prevent volume depletion; the control animals were given tap water. All animals had free access to food (Purina Chow containing 20% protein). The animals were killed 7 days after surgery, and the ventricular myocardium was used for experiments.
METHODS

Chemicals
Isolation of SR vesicles. SR membrane vesicles were isolated from the ventricular myocardium of control, adrenalectomized, and adrenalectomized/dexamethasone-treated rats according to the procedure described previously (15) . After isolation, the SR vesicles were suspended in 10 mM Trismaleate (pH 6.8) containing 100 mM KCl, quick-frozen in liquid N 2, and then stored at Ϫ80°C. Protein was determined by the method of Lowry et al. (21) using bovine serum albumin as standard. The yield of SR membranes from the hearts of the three groups of rats was similar (ϳ1.5 mg protein/g wet tissue). The relative purity of the cardiac SR vesicles from the three groups of rats did not differ as judged from essentially similar protein profiles revealed by SDSpolyacrylamide gel electrophoresis (SDS-PAGE, see RESULTS) .
Preparation of muscle homogenates. In addition to the SR, homogenates from control, adrenalectomized, and adrenalectomized/dexamethasone-treated rat hearts were also used in some experiments. The homogenates were prepared by homogenizing the ventricular tissue in 10 volumes (based on tissue weight) of 10 mM Tris-maleate-100 mM KCl buffer (pH 6.8) using a polytron PT-10 homogenizer (three 15 . In experiments where Ca 2ϩ concentration dependence was studied, the EGTA concentration in the assay medium was held constant at 0.1 mM and the amount of total 45 CaCl2 added was varied to yield the desired free Ca 2ϩ . The initial free Ca 2ϩ concentration was determined using the computer program of Fabiato (9) . To evaluate the effects of endogenous CaM kinase II-mediated phosphorylation on Ca 2ϩ uptake, the assays were performed in the absence of calmodulin and in the presence of 1 M calmodulin in the incubation medium. Other modifications to the standard assay medium are specified in the figure legends. The Ca 2ϩ -uptake reaction was initiated by the addition of SR to the rest of the assay components, preincubated for 3 min at 37°C, and allowed to proceed for 2 min, during which the Ca 2ϩ uptake rates were found to be linear. The data on Ca 2ϩ concentration dependence on Ca 2ϩ uptake were analyzed by nonlinear regression curve fitting using the SigmaPlot scientific graph program (Jandel Scientific) run on an IBM personal computer. The data were fit to the equation
where v is the measured Ca 2ϩ uptake rate at a given Ca 2ϩ concentration, Vmax is the maximum rate reached, K0.5 is the Ca 2ϩ concentration giving half of Vmax, and nH is the equivalent to the Hill coefficient. Ca 2ϩ -ATPase activity of the SR membrane vesicles was determined as described previously (25) using the assay conditions specified below. The incubation medium used for the Ca 2ϩ -ATPase assay was identical to that described for Ca 2ϩ uptake except that [␥-32 P]ATP was used instead of nonradioactive ATP and nonradioactive CaCl2 was used instead of 45 CaCl2. The assays were performed in the absence and presence of thapsigargin (TG). When present, the concentration of TG in the assay medium was 0.1 M, the concentration found to produce complete inhibition of Ca 2ϩ sequestration by the SR (35) . In these experiments, the TG-inhibitable ATP hydrolysis was defined as the Ca 2ϩ -ATPase activity (designated "TG-sensitive Ca 2ϩ -ATPase activity" in RESULTS). The ATPase reaction was initiated by the addition of SR after preincubation of the rest of the assay components for 3 min at 37°C and was allowed to proceed for 3 min. The longer reaction time used for the measurement of Ca -ATPase activity associated with rat cardiac SR vesicles (23) .
Immunoblotting of SR Ca 2ϩ -cycling proteins. Western immunoblotting techniques were used for the detection and estimation of the relative amounts of SR Ca 2ϩ -cycling proteins in the rat heart. 2ϩ -ATPase, phospholamban, and calsequestrin) or antirabbit (for CaM kinase II) IgG at a dilution of 1:5,000 was used as the secondary antibody. Protein bands reactive with antibodies were visualized using the enhanced chemiluminescence detection system from Amersham. The images of the protein bands were optimized, captured, and analyzed by ImageMaster VDS gel documentation system (Pharmacia Biotech; San Francisco, CA). The Western blotting detection system was determined to be linear with respect to the amount of SR/homogenate protein in the range of 10-40 g using this camera-based densitometry system.
Phosphorylation assay. Phosphorylation of SR proteins by endogenous CaM kinase II was determined as described previously (44) . The assay medium (total volume 50 l) for phosphorylation by endogenous CaM kinase II contained 50 mM HEPES (pH 7.4), 10 mM MgCl 2, 0.2 mM CaCl2, 0.2 mM EGTA, 1 M calmodulin, 0.8 mM [␥-
32 P]ATP (specific activity 200-300 cpm/pmol), and SR (25 g protein). The initial free Ca 2ϩ concentration, determined using the computer program of Fabiato (9), was 5.4 M. The phosphorylation reaction was initiated by the addition of [␥-
32 P]ATP after preincubation of the rest of the assay components for 3 min at 37°C. Reactions were terminated after 2 min by adding 15 l of SDS-sample buffer, and the samples were subjected to SDS-PAGE in 4-18% gradient gels, stained with Coomassie brilliant blue, dried, and autoradiographed (14) . Quantification of phosphorylation was carried out by liquid scintillation counting after careful excision of the radioactive bands from the gels (14) .
Data analysis. Results are presented as means Ϯ SE. Statistical significance was evaluated with a single-factor analysis of variance with the Tukey multiple comparison test. P Ͻ 0.05 was taken as a level of significance. Fig. 1 compare the rates of ATP-driven Ca 2ϩ uptake into cardiac SR vesicles from control, adrenalectomized, and adrenalectomized/dexamethasone-treated rats, measured in the absence and presence of Ca 2ϩ -release channel blockers. These assays were performed at a fixed Ca 2ϩ concentration (8.2 M) adequate for maximal activation of Ca 2ϩ uptake (cf Fig. 2 ). At concentrations known to block Ca 2ϩ release (5, 48), ruthenium red (25 M) and ryanodine (625 M) both stimulated the rates of Ca 2ϩ uptake by SR significantly in control and adrenalectomized/dexamethasone-treated rats. A similar tendency was also observed in the adrenalectomized group, but the difference was not statistically significant. The membranes from adrenalectomized rats showed significantly reduced (ϳ40% decrease) rates of Ca 2ϩ uptake compared with the membranes from control animals in both the absence and presence of Ca 2ϩ -release channel blockers. The membranes from adrenalectomized/dexamethasone-treated animals showed restoration of the higher rates of Ca 2ϩ uptake compared with those from adrenalectomized animals in both the absence and presence of Ca 2ϩ -release channel blockers.
RESULTS
Effects of adrenalectomy and dexamethasone treatment on the
In additional experiments, Ca 2ϩ uptake by SR was measured at varying Ca 2ϩ concentrations in the presence of ruthenium red (25 M) in the assay medium, and the results are summarized in Fig. 2 . At the wide range of Ca 2ϩ concentrations tested, the rate of Ca 2ϩ uptake by cardiac SR vesicles from adrenalectomized animals was significantly lower than that of the membranes from control animals. A significantly higher rate of Ca 2ϩ uptake by cardiac SR vesicles from adrenalectomized/dexamethasone-treated compared with untreated adrenalectomized animals could be observed at all Ca 2ϩ concentrations. The kinetic parameters derived from the data shown in Fig. 2 are summarized in Table 1 . Adrenalectomy and dexamethasone treatment did not appear to significantly influence the concentrations of Ca 2ϩ required for half-maximal velocity (K 0.5 ) or the Hill coefficient (n H ), whereas the V max values were diminished significantly.
Effects of adrenalectomy and dexamethasone treatment on the energy transduction function of Ca 2ϩ -ATPase in cardiac SR. The effect of adrenalectomy and dexamethasone treatment on the energy transduction function of the Ca 2ϩ -ATPase was assessed by measuring TG-sensitive ATP hydrolysis in cardiac SR vesicles. As shown in Fig. 3 , the rate of ATP hydrolysis measured was not affected significantly by adrenalectomy. Treatment of adrenalectomized animals with dexamethasone, however, led to a significant increase (ϳ70%) in the rate of ATP hydrolysis. The stoichiometry of Ca 2ϩ uptake/ATP hydrolysis by cardiac SR vesicles was not improved by treatment of adrenalectomized animals with dexamethasone. The estimated ratios of Ca 2ϩ uptake to TG-sensitive ATP hydrolysis were as follows: control, 0.59; adrenalectomized, 0.37; and adrenalectomized/dexamethasone-treated, 0.33. As discussed elsewhere (23) , such low stoichiometry between Ca 2ϩ uptake and ATP hydrolysis has been reported in several published studies using rat cardiac SR vesicles; the reasons for the apparently low efficiency of coupling ATP hydrolysis to Ca 2ϩ transport in rat cardiac SR vesicles in vitro remain unclear.
Effects of adrenalectomy and dexamethasone treatment on cardiac SR Ca 2ϩ -cycling proteins and their phosphorylation by endogenous CaM kinase II.
Major Ca 2ϩ -cycling proteins in the SR include the RyR-CRC responsible for Ca 2ϩ release into the cytosol on myocyte excitation to induce muscle contraction (4); Ca 2ϩ -ATPase, which actively sequesters Ca 2ϩ back into the SR lumen to promote muscle relaxation (22); calsequestrin, which serves to bind and store Ca 2ϩ within the SR lumen (22) ; and phospholamban, which serves to regulate Ca 2ϩ -ATPase function (17, 34, 38) . In the present study, we used antibodies specific for each of these SR Ca 2ϩ -cycling proteins to perform Western blotting analysis of their relative amounts in cardiac SR isolated from control, adrenalectomized, and adrenalectomized/dexamethasone-treated rats. The results of these experiments are summarized in Fig. 4 . No significant change was evident in the relative amounts of RyR-CRC, Ca 2ϩ -ATPase, calsequestrin, and phospholamban in cardiac SR after adrenalectomy or dexamethasone treatment. Similar findings were also obtained in experiments in which Western blot analysis of these proteins was performed using unfractionated cardiac muscle homogenates from all three groups (re- Fig. 2 . Effects of varying the calcium concentration of the incubation medium on ATP-dependent calcium uptake rate by cardiac SR vesicles from control, ADX, and ADX ϩ DEX rats. Calcium uptake assays were performed as described in METHODS. The assay medium contained 25 M RR, and the free Ca 2ϩ concentration was varied as shown. The data represent means Ϯ SE of 6 experiments using separate SR preparations in each case. Values are means Ϯ SE; n ϭ 6 rats. Values were derived from data shown in Fig. 2 by using the procedure described in METHODS. ADX, adenalectomized; DEX, dexamethasone; nH, Hill coefficient. * P Ͻ 0.05 vs. control or ADX ϩ DEX. CaM kinase II associated with the SR (and present in the cytosol) is implicated in the regulation of the Ca 2ϩ -uptake and -release functions of the cardiac SR through phosphorylation of phospholamban (17, 34, 38) , RyR-CRC (10, 19, 43) , and Ca 2ϩ -ATPase (11, 26-28, 30, 40, 44-47) . We determined endogenous CaM kinase-catalyzed protein phosphorylation in cardiac SR vesicles isolated from control, adrenalectomized, and adrenalectomized/dexamethasone-treated rats. Figure 5 shows the protein profiles of cardiac SR vesicles isolated from each experimental group and the corresponding autoradiogram depicting protein phosphorylation. In the presence of Ca 2ϩ and calmodulin, SR-associated CaM kinase II catalyzed the phosphorylation of RyR-CRC, Ca 2ϩ -ATPase, and phospholamban. No significant change in the phosphorylation of these Ca 2ϩ -cycling proteins was evident after adrenalectomy. On the other hand, dexamethasone treatment of adrenalectomized animals led to a significantly higher level of phosphorylation of all three CaM kinase II substrates. In several experiments, phosphorylation was quantified by determining 32 P incorporation into the protein bands excised from gels (see METHODS). The results confirmed the significantly higher level (50-80% increase) of substrate phosphorylation in the dexamethasone-treated group (Fig. 6) . Endogenous CaM kinase II levels in control, adrenalectomized, and dexamethasone-treated rats. We utilized a polyclonal antibody, specific for the ␦-isoform of CaM kinase II predominantly expressed in the heart (2, 7, 33) , to perform Western blotting analysis of this enzyme in cardiac SR from control, adrenalectomized, and adrenalectomized/dexamethasone-treated rats. As shown in Fig. 7 , the relative amount of ␦-CaM kinase II protein was found to be ϳ2.5-to 4-fold higher in the adrenalectomized/dexamethasone-treated group compared with control or adrenalectomized groups. No statistically significant difference was observed in the level of SR-associated CaM kinase II protein in the adrenalectomized group compared with the control group.
Effect of activation of endogenous CaM kinase II on Ca 2ϩ uptake by SR. To compare the effect of endogenous CaM kinase II activation on Ca 2ϩ uptake by cardiac SR from the three groups of rats, ATP-dependent Ca 2ϩ uptake by SR was determined in the absence and presence of calmodulin in the assay medium. Under the experimental conditions employed, the addition of calmodulin to the Ca 2ϩ uptake assay medium promotes phosphorylation of CaM kinase II substrates. These experiments were performed in the absence of ruthenium red in the assay medium because this drug Fig. 4 . Detection and estimation of relative amounts of Ca 2ϩ cycling proteins in cardiac SR isolated from control, ADX, and ADX ϩ DEX rats by Western blotting. Identical amounts of SR membranes (25 g protein) from the three groups of rats were subjected to Western immunoblotting analysis of Ca 2ϩ -sequestering ATPase (Ca 2ϩ -ATPase), RyR-CRC, calsequestrin, and phospholamban as described in METHODS. Representative immunoblots obtained with 3 separate SR preparations each from control, ADX, and ADX ϩ DEX rats are shown at the bottom. The content of each Ca 2ϩ cycling protein was quantified by computer-assisted analysis of Western blots using ImageMaster VDS software, and the results were obtained using 6 separate cardiac SR preparations from each group of rats are presented as means Ϯ SE in bar graphs. For each protein, the arbitrary units shown were derived at same software settings form two separate Western blots, each containing 3 different SR preparations from each group of rats. -ATPase phosphorylation by CaM kinase II (28) . As shown in Fig. 8 , the presence of calmodulin (1 M) in the assay medium resulted in stimulation of Ca 2ϩ uptake by cardiac SR vesicles from control, adrenalectomized, and adrenalectomized/dexamethasone-treated rats. The stimulatory effect of calmodulin was most pronounced in the dexamethasone-treated group (ϳ74% increase) and was minimal in the adrenalectomized group (ϳ25% increase).
DISCUSSION
In this study, we made the following key observations: 1) The ATP-dependent Ca 2ϩ uptake rate (Ca 2ϩ -pump function) of cardiac SR membrane vesicles in -ATPase (B), and phospholamban (C) in cardiac SR isolated from control, ADX, and ADX ϩ DEX rats. After phosphorylation under standard assay conditions in the presence of Ca 2ϩ and CaM, SR proteins were fractioned by SDS-PAGE, and 32 P incorporation into peptide bands representing RyR-CRC, Ca 2ϩ -ATPase, and phospholamban was determined by liquid scintillation counting as described in METHODS. The data for phospholamban include 32 P incorporation into both LMW and HMW forms of this protein. Data represent means Ϯ SE of 6 experiments using separate SR preparations in each case. *P Ͻ 0.05 vs. control or ADX. Fig. 7 . Detection and estimation of relative amounts of ␦-CaM kinase II in cardiac SR isolated from control, ADX, and ADX ϩ DEX rats by Western blotting. Identical amounts of cardiac SR membranes (25 g protein) from control, ADX, and ADX ϩ DEX rats were subjected to Western immunoblotting analysis of CaM kinase II (␦-isoform) as described in METHODS. Immunoblots obtained with 3 separate SR preparations each from control, ADX, and ADX ϩ DEX rats are shown at the bottom. CaM kinase II content was quantified by computer-assisted analysis of Western blots using ImageMaster VDS software as described in the legend to Fig. 4 , and the results obtained using 6 cardiac SR preparations from each group of rats are presented as means Ϯ SE in the bar graph. *P Ͻ 0.05 vs. control or ADX.
vitro is markedly reduced following adrenalectomy; treatment of adrenalectomized animals with dexamethasone prevents this decline in SR Ca 2ϩ transport function.
2) The levels of the major Ca 2ϩ -cycling proteins (Ca 2ϩ -ATPase, RyR-CRC, calsequestrin, and phospholamban) in cardiac SR are not altered significantly after adrenalectomy or dexamethasone treatment. 3) Treatment of adrenalectomized animals with dexamethasone leads to a striking increase in the amount of ␦-CaM kinase II associated with cardiac SR, as well as significantly enhanced substrate (Ca 2ϩ -ATPase, RyR-CRC, and phospholamban) phosphorylation by the endogenous CaM kinase II. These findings clearly identify the SR membrane as a major subcellular target for glucocorticoid actions in the heart, and, as discussed below, they provide insights into the mechanisms underlying glucocorticoid modulation of cardiac contractile function.
Although systematic studies on the rates of contraction and relaxation of cardiac muscle from adrenaldeficient animals seem to be lacking, cardiac muscle from dexamethasone-treated intact animals has been shown to display markedly increased contractile tension as well as rates of contraction and relaxation (31) . The present findings suggest strongly that the dexamethasone-mediated increase in the velocity of muscle relaxation might arise, at least in part, from the ability of this glucocorticoid to augment the SR Ca 2ϩ -pump activity. Because the SR Ca 2ϩ -pump activity is a major determinant of SR Ca 2ϩ load (and hence, the amount of Ca 2ϩ available for release) (13, 36, 42) , the increased SR Ca 2ϩ -pump activity may also contribute to the enhanced velocity of contraction (31) and contractile tension (19) observed in dexamethasone-treated animals. Conversely, the diminished Ca 2ϩ -pump activity of cardiac SR from adrenalectomized animals reported here correlates well with the depression of myocardial contractility observed in adrenal deficiency in vivo (41) and in vitro (19) . The Ca 2ϩ -ATPase content (Fig. 4) and Ca 2ϩ -ATPase activity (Fig. 3 ) of cardiac SR were not altered significantly by adrenalectomy. Therefore, the observed decline in SR Ca 2ϩ -pump function is likely due to impaired Ca 2ϩ translocation rather than energy transduction. This apparent uncoupling of ATP hydrolysis and Ca 2ϩ transport does not appear to be due to enhanced Ca 2ϩ leak from the SR because SR Ca 2ϩ -release channel blockers did not abolish or attenuate the depression in Ca 2ϩ -uptake activity of SR from adrenalectomized animals (Fig. 1) . The impaired SR Ca 2ϩ -pump function after adrenalectomy and the improvement after dexamethasone treatment may involve alterations in the membrane-associated glycogenolytic pathway. Previous studies have demonstrated a marked and selective depletion and restoration of both active and total phosphorylase activities in the rat heart microsomes after adrenalectomy and dexamethasone treatment, respectively (24) . A strong association of substantial amounts of phosphorylase, glycogen, and other enzymes linked to glycogenolysis with the SR membrane in cardiac muscle has been documented in earlier studies (8) , suggesting that the glycogenolytic pathway present in the membrane might serve as a link between excitation-contraction coupling and intermediary metabolism. It is possible that the loss of phosphorylase from the SR membrane in adrenal insufficiency might result in derangement of the link between excitation-contraction coupling and intermediary metabolism.
To our knowledge, the present study is the first to provide evidence of phosphorylation-dependent glucocorticoid modulation of SR function. Our results revealed a significant increase in the CaM kinase IImediated phosphorylation of RyR-CRC, Ca 2ϩ -ATPase, and phospholamban after dexamethasone treatment, although no significant change was observed due to adrenalectomy per se (Figs. 5 and 6 ). Because dexamethsone treatment did not significantly alter the levels of CaM kinase II substrates, this increase in phosphorylation may be attributed to the observed increase in the amount of ␦-CaM kinase II, which is the predominant CaM kinase II isoform present in cardiac cytosol and SR (2, 7, 33) . The functional consequence of cardiac RyR-CRC phosphorylation has not been clearly established. Recently, CaM kinase II inhibitors as well as protein phosphatases have been found to reduce SR Ca 2ϩ -release channel activity in intact cardiomyocytes (6, 20) . These findings are consistent with an increased SR Ca 2ϩ -release channel activity on RyR-CRC phosphorylation by CaM kinase II. In any case, the observed increase in the RyR-CRC phosphorylation after dexamethasone treatment can be expected to impact on the modulation of SR Ca 2ϩ release and, therefore, myofilament activation. Phosphorylation of phospholamban by PKA (at Ser 16 ) and CaM kinase II (at Thr 17 ) is well known to stimulate Ca 2ϩ uptake by SR, apparently by relieving an inhibitory effect exerted by de- phosphorylated phospholamban on the Ca 2ϩ -ATPase (17, 34, 38) . Recently, Ser 38 phosphorylation of the cardiac SR Ca 2ϩ -ATPase by CaM kinase II also was shown to result in stimulation of ATP hydrolysis (44) and Ca 2ϩ transport (11, 27, 30, 40, 45) . Although some studies (29, 32) -cycling proteins in cardiac muscle after dexamethasone treatment of adrenalectomized animals suggest an important modulatory role for glucocorticoids in the maintenance of normal SR function and, therefore, cellular Ca 2ϩ homeostasis in the myocardium. In this regard, it is also noteworthy that the stimulatory effect of protein phosphorylation by endogenous CaM kinase II on the Ca 2ϩ -uptake function of SR was clearly more pronounced in the dexamethasone-treated animals (Fig. 8) . Thus modification of SR-associated CaM kinase II system appears to be a key component of the mechanisms by which dexamethasone influences SR Ca 2ϩ -cycling and myocardial contraction. It is intriguing that adrenalectomy per se did not result in a significant decline in the level of CaM kinase II protein in the cardiac SR membrane. Therefore, it is not clear whether endogenously occurring glucocorticoids influence the SR-associated CaM kinase II system in a manner similar to that observed in this study after exogenous administration of the synthetic glucocorticoid dexamethasone.
